Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, today announced the release of new findings concerning the effect of Bacillus-derived Hyaluronic Acid (HA) on the drug ...

According to a statement issue by the company, it received final approval from the US Food and Drug Administration (USFDA) to manufacture and market the drug. The state's drug controller suspended the ...

The opioid pain-reliever tramadol appears to be associated with an increased risk of hospitalization for hypoglycemia, a potentially fatal condition caused by low blood sugar, according to a report.

Product to be Launched in the U.S. in the Second Quarter of 2009 LAVAL, QC, Dec. 31 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced ...

June 2, 2005 — The U.S. Food and Drug Administration (FDA) has approved extended-release dexmethylphenidate HCl capsules for once-daily treatment of attention deficit/hyperactivity disorder in adults, ...

Aurobindo Pharma Ltd has informed BSE regarding a Press Release dated October 23, 2015 titled "Aurobindo Pharma receives USFDA Approval for Tramadol Hydrochloride Extended-release Tablets".Source : ...

Extended-release formulations of tramadol hydrochloride (tramadol ER) (multiple brands) may provide an alternative treatment option for reducing withdrawal symptoms in patients with opioid use ...

A pharmacists holds a bottle of traMADOL Hydrochloride made by Sun Pharma at a pharmacy, in Provo, Utah SYDNEY (Reuters) - The World Anti-Doping Agency will add the painkiller tramadol to the list of ...